Genome-wide miRNA-profiling of aflatoxin B1-induced hepatic injury using deep sequencing

Toxicology Letters

Volumn 226, Issue 2, 2014, Pages 140-149

  Yang, Weiqiang ^a   Lian, Junwei ^a   Feng, Youjun ^a,b   Srinivas, Swaminath ^b   Guo, Zhenni ^a   Zhong, Hong ^a   Zhuang, Zhenhong ^a   Wang, Shihua ^a  

^a FUJIAN AGRICULTURE AND FORESTRY UNIVERSITY   (China)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Aflatoxin B1; Hepatocellular carcinoma; High throughput sequencing; MicroRNA

Indexed keywords

AFLATOXIN B1; MICRORNA; MICRORNA 122; MICRORNA 140; MICRORNA 151; MICRORNA 203; MICRORNA 221; MICRORNA 28; MICRORNA 338; MICRORNA 34A; MICRORNA 423; MICRORNA 92A; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LIBRARY; GENE TARGETING; HIGH THROUGHPUT SEQUENCING; INFANT; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ANALYSIS; RNA SEQUENCE;

AFLATOXIN B1; HEPATOCELLULAR CARCINOMA; HIGH-THROUGHPUT SEQUENCING; MICRORNA;

AFLATOXIN B1; ANIMALS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DRUG-INDUCED LIVER INJURY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; RATS; RATS, INBRED F344; REPRODUCIBILITY OF RESULTS; RNA PRECURSORS;

EID: 84896047509     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.01.021     Document Type: Article

References (39)

1. Allen E., Xie Z. microRNA-directed phasing during trans-acting siRNA biogenesis in plants. Cell 2005, 121:207-221.
2. Asim M., Sarma M.P., Thayumanavan L., Kar P. Role of AFB1 as a risk for primary liver cancer in north Indian population. ClinBiochem 2011, 44:1235-1240.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15524-15529.
5. Chen C., Ridzon D.A., Broomer A.J. Real-time quantification of microRNAs bystem-loop RT-PCR. Nucleic Acids Res. 2005, 33:179.
6. Chen X., Gong J., Zeng H., Chen N., Huang R., Huang Y., Nie L., Xu M., Xia J., Zhao F., Meng W., Zhou Q. MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res. 2011, 70:2728-2738.
7. Croy R.G., Essigmann J.M., Reinhold V.N., Wogan G.N. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. PNAS 1978, 75:1745-1749.
8. Farazi T.A., Horlings H.M., Ten Hoeve J.J. MicroRNA sequence and expression analysis in breast tumors by deep sequencing. Cancer Res. 2011, 71:4443-4453.
9. Furuta M., Kozaki K.I., Tanaka S., Arii S., Imoto I., Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010, 31:766-776.
10. Gijssel H.E., Maassen C.B., Mulde G.J., Meerman J.H. p53 protein expression by hepatocarcinogens in the rat liver andits potential role in mitoinhibition of normal hepatocytes as amechanism of hepatic tumour promotion. Carcinogenesis 1997, 18:1027-1033.
11. Gramantieri L., Ferracin M., Fornari F. Cyclin G1 is a target of miR-122a, a MicroRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res. 2007, 67:6092-6099.
12. Gramantieri L., Fornari F., Ferracin M. microRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin. Cancer Res. 2009, 15:5073-5081.
13. Habig J.W., Dale T., Bass B.L. miRNA editing-we should have inosine this coming. Mol. Cell. 2007, 25:792-793.
14. Hayashita Y., Osada H., Tatematsu Y. A polycistronic microRNA cluster, miR-17-92, is proliferation overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005, 65:9628-9632.
15. Huang Y.S., Dai Y., Yu X.F., Bao S.Y., Yin Y.B., Tang M., Hu C.X. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J. Gastroentrol. Hepatol. 2008, 23:87-94.
16. Huang X.H., Wang Q., Chen J.S. Bead-based microarray analysis of microRNA expression inhepatocellular carcinoma: miR-338 is downregulated. Hepato Res. 2009, 39:786-794.
17. Ladeiro Y., Couchy G., Balabaud C., Bioulac S.P., Pelletier L., Rebouissou S., Zucman R.J. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008, 47:1955-1963.
18. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
19. Li R., Li Y., Kristiansen K., Wang J. SOAP: short oligonucleotide alignment program. Bioinformatics 2008, 24:713-714.
20. Liu Y., Wu F. Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ. Health Perspect. 2010, 118:818-824.
21. Liu C., Kelnar K., Liu B. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 2011, 17:211-215.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Method 2001, 25:402-408.
23. Mendell J.T. miRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133:217-222.
24. Michael M.Z., O'Connor S.M., van Holst Pellekaan N.G., Young G.P., James R.J. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 2003, 1:882-891.
25. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25:2537-2545.
26. Okoniewski M.J., Miller C.J. Hybridization interactions between probesets in short oligo microarrays lead to spurious correlations. BMC Bioinformatics 2006, 7:276.
27. Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991, 338:1356-1359.
28. Schwab R., Palatnik J.F. Specific effects of microRNAs on the plant transcriptome. Dev. Cell 2005, 8:517-527.
29. Subramanian S., Lui W.O., Lee C.H., Espinosa I., Nielsen T.O., Heinrich M.C., Corless C.L., Fire A.Z., Rijn M. MicroRNA expression signature of human sarcomas. Oncogene 2008, 27:2015-2026.
30. Sun J., Zhong N., Li Q. microRNAs of rat articular cartilage at different developmental stages identified by Solexa sequencing. Osteoarthritis Cartilage 2011, 19:1237-1245.
31. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:29-33.
32. Tarasov V., Jung P., Verdoodt B. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007, 13:1586-1593.
33. Williams J.H., Phillips T.D., Jolly P.E., Stiles J.K., Jolly C.M., Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am. J. Clin. Nutr. 2004, 80:1106-1122.
34. Wu H.C., Santella R. The role of aflatoxins in hepatocellular carcinoma. Hepat. Mon. 2012, 10:e7238.
35. Xiao C., Srinivasan L., Calado D.P. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 2008, 9:405-414.
36. Yi F., Youjun F., Tongjin W., et al. Aflatoxin B1 negatively regulates Wnt/β-Catenin signaling pathway through activating miR-33a. PLoS ONE 2013, 8:e73004.
37. Zhang L., Huang J., Yang N. microRNAs exhibit high frequency genomic alterations in human cancer. PNAS 2006, 103:9136-9141.
38. Zhang X., Yu H., Lou J.R., Zheng J., Zhu H., Popescu N.I., Lupu F., Lind S.E., Ding W.Q. MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J. Biol. Chem. 2011, 286:1429-1435.
39. Zhang J., Chiodini R., Badr A., Zhang G. The impact of next-generation sequencing on genomics. J. Genet. Genomics 2011, 38:95-109.